Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04112030
Other study ID # DIA and biliary stricture
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2016
Est. completion date March 2018

Study information

Verified date September 2019
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study aimed to assess role of DIA in diagnosing nature of indeterminate bile ducts stricture


Description:

Biliary strictures (BSs) are common in clinical practice, but differentiating nature of the stricture either benign or malignant remains a challenge. Although there is a great advance in imaging and laboratory investigations, nature of BS is still unclear in some patients. Therefore, preoperative evaluation of such strictures is mandatory to put suitable plan with appropriate management.

BS is considered indeterminate biliary duct stricture (IBDS) if it has the following conditions; 1) no obvious mass on abdominal ultrasound (US), or magnetic resonance cholangiopancreatography (MRCP); 2) no distant metastasis on abdominal US, or MRI; and 3) no recent history of hepatobiliary surgery in the last 3 months.

IBDS has a particularly complex challenge, because patients and their physicians must weigh the malignant potential against benign etiologies in the face of morbidity of surgical intervention. About 15-24% of the patients had surgical intervention for suspected IBDS have a benign aetiology. Therefore, preoperative evaluation of such strictures is mandatory to put suitable plan with appropriate management.

Conventional cytological evaluation (CCE) has become the standard modality of practice for the investigation of such stricture. CCE had low diagnostic yield with an overall sensitivity of 41.6% and a negative predictive value of 58%. This low diagnostic yield is mainly attributed to desmoplastic reaction in BS.

Radiological elevation of BS with different modalities as MRCP enables us to detect the stricture and its extent and exclude other causes of obstruction. These modalities fail to determine nature of BS in many cases. In addition to, inability to take tissue sampling or perform therapeutic intervention.

Recently, there is a great advance in endoscopic assessment of BS as cholangioscopy, intraductal ultrasonography (IDUS), and confocal laser endomicroscopy. These techniques have high diagnostic yield in diagnosing nature of BS but secondary to high cost, complexity, and unavailability of these procedures, making them of limited use in evaluation the nature of IBDS.

Advanced cytological techniques have been emerged to identify nature of IBDS i.e., digital image analysis (DIA), and fluorescence in-situ hybridization (FISH) where both techniques detect the chromosomal alterations in malignant cells.

FISH is significantly more sensitive than CCE for assessment the nature of IBDS. However, the specificity of FISH was poor compared to the excellent specificity of CCE. The compromised specificity of FISH may limit its utility in the detection of nature of IBDS.

DIA has been widely used in many malignant diseases, especially in cervical cancer where it had 70% to 91.7%, sensitivity and 54.1% to 100% specificity for the diagnosis of different malignant diseases in published studies.

Role of DIA in pancreatobiliary malignancies is still controversial. Also, there are limited studies that have addressed the use of DIA in diagnosing the nature of IBDS. In addition to unavailability, the high cost and the complexity of advanced endoscopes, we designed this work to evaluate the diagnostic performance of DIA in identification nature of IBDS in comparison to CCE. Also, we perform a cost analysis of DIA vs. CCE in diagnosing nature of IBDS.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date March 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Any patient presented with biliary stricture with no obvious cause in abdominal imaging

Exclusion Criteria:

- biliary obstruction due to other causes as stones, or tumor,

- biliary surgery within the last six months

- Coagulopathy

- lost follow up

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Digital image analysis


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (2)

Aljahdli ES. Management of distal malignant biliary obstruction. Saudi J Gastroenterol. 2018 Mar-Apr;24(2):71-72. doi: 10.4103/sjg.SJG_611_17. — View Citation

Park JY, Jeon TJ. Factors Associated with Malignant Biliary Strictures in Patients with Atypical or Suspicious Cells on Brush Cytology. Clin Endosc. 2019 Mar;52(2):168-174. doi: 10.5946/ce.2018.105. Epub 2019 Jan 9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic performance of DIA compared to routine cytology in case of IBDS all samples were subjected to DIA and routine cytology and the result was compared with final diagnosis Baseline
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04550819 - Intraintestinal Extended Biliary Stents Preventing Duodenobiliary Reflux in Patients With Biliary Stricture N/A
Recruiting NCT04929821 - UNITY-B A Prospective, Multicentric, Single-arm Study to Evaluate the Safety and Efficacy of the UNITY-B Biodegradable Balloon-Expandable Biliary Stent System in Subjects With Biliary Strictures N/A
Completed NCT02000999 - Diagnosis of Bile Duct Strictures
Completed NCT01227382 - Accuracy of Spybite Forceps When Compared to Conventional Sampling Methods N/A
Completed NCT04604652 - Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis Phase 2
Recruiting NCT01818050 - Prospective Evaluation of Stent Patency in Patients With Benign Biliary Obstruction of the Wing Biliary Stent (Viaductâ„¢) Phase 4
Completed NCT02442167 - Performance of FISH for the Diagnosis of Malignant Biliary Strictures in Thai Patients
Recruiting NCT03763214 - PTFE Stents for Treatment of Malignant Biliary Strictures N/A
Recruiting NCT03716232 - Kaffes Stent in the Management of Post-surgical Biliary Strictures Phase 3
Recruiting NCT03310554 - Suspended Overlength Biliary Stents Preventing Duodenobiliary Reflux in Patients With Biliary Stricture N/A
Completed NCT01815619 - Comparison of On-Site Versus Off-Site Evaluation of Cholangioscopy-Guided Biopsies of the Bile Duct N/A
Recruiting NCT03788655 - Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct Tract
Completed NCT02276157 - Direct Peroral Cholangioscopy by Using an Ultra-slim Upper Endoscope N/A
Recruiting NCT01414400 - Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde Cholangiopancreatography). N/A
Completed NCT05556668 - Percutaneous Biodegradable Biliary Stents for the Treatment of Benign Biliary Strictures.
Recruiting NCT05320497 - Transparent Cap-assisted SpyGlass for Biliary Stricture N/A